This study reveals that artificial intelligence can revolutionize combination therapies by converting ineffective or harmful drug interactions ...

Japan's genome editing market, valued at USD 1.45 billion by 2033, grows at a 17.97% CAGR, driven by precision medicine and biotech investment. Key t ...